comparemela.com

Latest Breaking News On - Genetics stock down - Page 4 : comparemela.com

Cancer Genetics (NASDAQ:CGIX) Coverage Initiated by Analysts at StockNews com

StockNews.com assumed coverage on shares of Cancer Genetics (NASDAQ:CGIX – Get Rating) in a research report report published on Saturday morning. The brokerage issued a sell rating on the stock. Cancer Genetics Stock Down 15.8 % Cancer Genetics stock opened at $0.19 on Friday. Cancer Genetics has a 52 week low of $2.11 and a […]

Fulgent Genetics, Inc (NASDAQ:FLGT) COO Sells $57,749 90 in Stock

Fulgent Genetics, Inc. (NASDAQ:FLGT – Get Rating) COO Jian Xie sold 1,433 shares of the company’s stock in a transaction dated Friday, June 2nd. The shares were sold at an average price of $40.30, for a total transaction of $57,749.90. Following the completion of the sale, the chief operating officer now directly owns 425,794 shares […]

StockNews com Begins Coverage on Cancer Genetics (NASDAQ:CGIX)

StockNews.com started coverage on shares of Cancer Genetics (NASDAQ:CGIX – Get Rating) in a research report released on Thursday morning. The brokerage issued a sell rating on the stock. Cancer Genetics Stock Down 9.6 % CGIX stock opened at $0.24 on Thursday. The business has a 50 day moving average price of $0.40 and a […]

StockNews com Initiates Coverage on Cancer Genetics (NASDAQ:CGIX)

Stock analysts at StockNews.com began coverage on shares of Cancer Genetics (NASDAQ:CGIX – Get Rating) in a research report issued on Saturday. The brokerage set a “sell” rating on the stock. Cancer Genetics Stock Down 2.3 % Shares of NASDAQ CGIX opened at $4.61 on Friday. Cancer Genetics has a twelve month low of $2.11 […]

Cancer Genetics (NASDAQ:CGIX) Coverage Initiated at StockNews com

StockNews.com started coverage on shares of Cancer Genetics (NASDAQ:CGIX – Get Rating) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the stock. Cancer Genetics Stock Down 6.2 % Shares of CGIX opened at $0.54 on Thursday. The firm has a market cap of $2.19 million, a […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.